Orlistat is a well-known irreversible inhibitor of pancreatic and gastric lipase, as well as a fatty acid synthase inhibitor [5], and it is commonly used to treat obesity and prevent atherosclerosis. Here, LIPF is linked to obesity due to melanocortin 4 receptor deficiency.